Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RESFRIN: Paracetamol/Fexofenadine/Phenylephrine FDC in Flu and Cold
NCT05118672Phase 3Completed
- Sponsor
- Eurofarma
- Start
- Mar 2025
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of acetaminophen, fexofenadine, phenylephrine in common cold, influenza, sponsored by Eurofarma. Started Mar 2025; status: completed.
02
Drugs
acetaminophenfexofenadinephenylephrine
03
Conditions
common coldinfluenza
Beyond the preview
Go deeper on NCT05118672.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05118672.